Literature DB >> 18625775

Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.

C J Seneviratne1, L J Jin, Y H Samaranayake, L P Samaranayake.   

Abstract

Biofilm formation is a major virulence attribute of Candida pathogenicity which contributes to higher antifungal resistance. We investigated the roles of cell density and cellular aging on the relative antifungal susceptibility of planktonic, biofilm, and biofilm-derived planktonic modes of Candida. A reference and a wild-type strain of Candida albicans were used to evaluate the MICs of caspofungin (CAS), amphotericin B (AMB), nystatin (NYT), ketoconazole (KTC), and flucytosine (5FC). Standard, NCCLS, and European Committee on Antibiotic Susceptibility Testing methods were used for planktonic MIC determination. Candida biofilms were then developed on polystyrene wells, and MICs were determined with a standard 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide assay. Subsequently, antifungal susceptibility testing was performed for greater inoculum concentrations and 24- and 48-h-old cultures of planktonic Candida. Furthermore, Candida biofilm-derived planktonic cells (BDPC) were also subjected to antifungal susceptibility testing. The MICs for both C. albicans strains in the planktonic mode were low, although on increasing the inoculum concentration (up to 1 x 10(8) cells/ml), a variable MIC was noted. On the contrary, for Candida biofilms, the MICs of antifungals were 15- to >1,000-fold higher. Interestingly, the MICs for BDPC were lower and were similar to those for planktonic-mode cells, particularly those of CAS and AMB. Our data indicate that higher antifungal resistance of Candida biofilms is an intrinsic feature possibly related to the biofilm architecture rather than cellular density or cellular aging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625775      PMCID: PMC2533466          DOI: 10.1128/AAC.00541-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Forging a link between biofilms and disease.

Authors:  C Potera
Journal:  Science       Date:  1999-03-19       Impact factor: 47.728

Review 2.  Candida biofilm resistance.

Authors:  Pranab K Mukherjee; Jyotsna Chandra
Journal:  Drug Resist Updat       Date:  2004 Aug-Oct       Impact factor: 18.500

Review 3.  Microbial biofilms.

Authors:  J W Costerton; Z Lewandowski; D E Caldwell; D R Korber; H M Lappin-Scott
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

4.  Resistance of Candida albicans biofilms to antifungal agents in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

5.  Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.

Authors:  Richard P Wenzel; Chris Gennings
Journal:  Clin Infect Dis       Date:  2005-09-15       Impact factor: 9.079

6.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

7.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars.

Authors:  Ye Jin; Lakshman P Samaranayake; Yuthika Samaranayake; Hak Kong Yip
Journal:  Arch Oral Biol       Date:  2004-10       Impact factor: 2.633

View more
  34 in total

1.  The controlled in vitro susceptibility of gastrointestinal pathogens to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-17       Impact factor: 3.267

2.  Enhanced Efflux Pump Activity in Old Candida glabrata Cells.

Authors:  Somanon Bhattacharya; Bettina C Fries
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.

Authors:  C J Seneviratne; S S W Wong; K Y Yuen; J H Meurman; P Pärnänen; M Vaara; L P Samaranayake
Journal:  Mycopathologia       Date:  2011-07-09       Impact factor: 2.574

4.  Comparative effect of propolis of honey bee and some herbal extracts on Candida albicans.

Authors:  Shahin Gavanji; Behrouz Larki
Journal:  Chin J Integr Med       Date:  2015-07-07       Impact factor: 1.978

Review 5.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

6.  Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Authors:  Margarida Martins; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycoses       Date:  2011-06-12       Impact factor: 4.377

7.  Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.

Authors:  Li-Hua Yu; Xin Wei; Ming Ma; Xiao-Jun Chen; Shuang-Bo Xu
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

8.  The impact of farnesol in combination with fluconazole on Candida albicans biofilm: regulation of ERG20, ERG9, and ERG11 genes.

Authors:  Stanislava Dižová; Lucia Černáková; Helena Bujdáková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-12       Impact factor: 2.099

9.  Probiotic Lactobacillus and Bifidobacterial Lectins Against Candida albicans and Staphylococcus aureus Clinical Strains: New Class of the Pathogen Biofilm Destructors.

Authors:  M Lakhtin; V Alyoshkin; V Lakhtin; S Afanasyev; L Pozhalostina; V Pospelova
Journal:  Probiotics Antimicrob Proteins       Date:  2010-10       Impact factor: 4.609

10.  Comparative Ploidy Proteomics of Candida albicans Biofilms Unraveled the Role of the AHP1 Gene in the Biofilm Persistence Against Amphotericin B.

Authors:  Thuyen Truong; Guisheng Zeng; Lin Qingsong; Lim Teck Kwang; Cao Tong; Fong Yee Chan; Yue Wang; Chaminda Jayampath Seneviratne
Journal:  Mol Cell Proteomics       Date:  2016-09-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.